Skip to main content
. 2024 Mar 7;67(1):e15. doi: 10.1192/j.eurpsy.2024.13

Table 2.

PP3M characteristics

PP3M Total
N = 97
Initial PP3M dose (n [%])
   525 mg 28 (28.9)
   350 mg 42 (43.3)
   263 mg 16 (16.5)
   175 mg 11 (11.3)
Dose change (n [%])
   None 83 (85.6)
   Increase (n [%]) 3 (3.1)
      Worsening symptoms 2 (66.7)
      Patient request 1 (33.3)
Decrease (n [%]) 11 (11.3)
   Patient request 5 (45.5)
   Adverse effects 4 (36.4)
   Improved condition 1 (9.1)
   Unclear 1 (9.1)